Sorry, you need to enable JavaScript to visit this website.
Study Startup

Can you help build an algorithm that is informed by completed study conduct to inform the designs of future studies that bring therapies to patients that need them?

Completed on Feb 14, 2020
Logarithmic graph teaser image
Overview

Our Goal

Use artificial intelligence to read and understand study protocols, Statistical Analysis Plans (SAP), and metadata standards to create a knowledge graph by linking relevant elements together. The ideal solution would leverage smart machines to think, read, and act like a human when reviewing various types of clinical documentation. Utilizing Natural Language Processing (NLP), the ideal solution should be capable of extracting and linking, for example, end points in a protocol, to visit schedule, to statistical techniques, in a SAP.

The Challenge

The pharmaceutical industry creates multiple documents when conducting a clinical trial. These range from a clinical study protocol document to a statistical analysis plan (SAP). These documents can live in various formats, platforms, and file types. The documents can contain unstructured data. Pfizer is looking to accelerate the translation of data to knowledge graphs such that it can lead to actionable insights, precise therapeutic interventions, and health care strategies. 

Results

Multiple selected companies participated in this targeted challenge. Each solution showed promise in its ability to build and train a “smart machine” to generate a document customized for a specific clinical trial protocol. The participating companies provided novel solutions using Natural Language Processing (NLP) technique to convert the protocol into useable “knowledge.” The accuracy varied among the participating companies--however a mechanism to “train the smart machine” would be necessary to improve accuracy. The results of this challenge showed that a knowledge graph is viable when built using NLP with pretrained models that are mature enough to perform named entity recognition. This technique can be leveraged to automate study build specifications and improve data lineage. 

About the Breakthrough Change Accelerator 

Pfizer’s Breakthrough Change Accelerator is a competitive incubation sandbox created to power rapid and robust machine learning in a secure environment. We invite innovators to collaborate on challenges using large volumes of relevant datasets to create novel technology solutions that speed up development of medicines to patients.